Dasatinib (Sprycel)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Dasatinib (Sprycel), covering 2011-04-14 to 2015-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]